News

Spero Therapeutics and partner GSK are stopping a late-stage trial of an experimental oral drug for complicated urinary tract ...
Watford MP Matt Turmaine emphasised the urgent need for a cure for chronic urinary tract infections (UTIs) at Parliament last ...
GSK and Spero Therapeutics’ Phase III trial of their oral antibiotic for complicated urinary tract infections (cUTI) will end ...
Spero Therapeutics (SPRO) stock jumps as GSK (GSK) partnered oral UTI treatment, tebipenem HBr, succeeds in a pivotal Phase 3 ...
Labour MP Allison Gardner has revealed that she got into politics to “give a voice” to women suffering from chronic urinary ...
The category's average allocation to large, mid, and smallcaps was 48.09 per cent, 12.63 per cent and 9.34 per cent, ...
A common over-the-counter drug used by millions to relieve UTI symptoms is now under serious scrutiny. Phenazopyridine — sold under brand names like Azo and Pyridium — has been linked to cancer in ...
GSK’s decision to swoop in and save Spero Therapeutics’ antibiotic three years ago appears to have paid off based on a fresh ...
Sufferer-turned-campaigner, Joanne McKinlay, has also dedicated her life to raising awareness for chronic UTI, setting a ...
Universal Technical Institute plans to open new San Antonio campus for skilled trades. Students can pursue HVAC, welding, ...
Patterson-UTI faces margin pressure amid lower oil prices and OPEC+ risks. Click here to read why I am downgrading PTEN stock ...
UTIs are among the most common infections worldwide, affecting some 15 million women a year. Phenazopyridine, sold under brand names such as Azo and Uristat, is used to treat the pain, burning and ...